How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.


Answers From the Lab

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss summertime illnesses and key insights from a recent diagnostic investment event. Together, they explore:

  • Common summertime illnesses, along with tips for prevention.
  • How investment in diagnostic tools influences innovation in the laboratory.
  • The potential impact of growing interest in AI investments.
  • The investment interest in liquid biopsy and its potential implications for clinical decision-making.
  • How AI development may accelerate adoption of mass spectrometry, proteomics, and similar advancements in clinical laboratories.

Podcast episode

Note: Podcasts will not playback on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.

Podcast episode in video format

Answers from the Lab is a Mayo Clinic Laboratories curated podcast sharing knowledge and advancements regarding the state of testing, laboratory science, and the people who make it all happen behind the scenes. 

Information in this post was accurate at the time of its posting.

Jessie Fenske

Jessie Fenske is a senior marketing specialist at Mayo Clinic Laboratories. She joined Mayo Clinic in 2010 and enjoys partnering with patients and employees to share their stories of innovation, persistence and hope.